Article info

Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD
Free
  1. Correspondence to Professor R Dahl, Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark; ronadahl{at}rm.dk
View Full Text

Citation

Dahl R, Chung KF, Buhl R, et al
Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD

Publication history

  • Received August 19, 2009
  • Accepted March 23, 2010
  • First published June 3, 2010.
Online issue publication 
June 03, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.